BIOSYNEX (ALBIO.PA) Stock Cash Flow
Europe - Euronext Paris - EPA:ALBIO - FR0011005933 - Common Stock
0.596 EUR
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -71.00M | -43.40M | -35.61M | 15.60M | 106.70M | |||
| Depreciation Amortization | 58.88M | 21.00M | 13.00M | 26.90M | 2.00M | |||
| Income Taxes - Deferred | -2.78M | -720.00K | -2.00M | -300.00K | 500.00K | |||
| Change In Working Capital | 10.62M | 13.00M | 15.00M | -37.30M | 600.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | -870.00K | 570.00K | -20.00K | 0.00 | 0.00 | |||
| OPERATING CASH FLOW | -6.07M | -10.00M | -9.65M | 4.90M | 109.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.35M | -4.84M | -40.00M | -30.10M | -19.00M | |||
| Other Investing Activity | 1.18M | 240.00K | -15.00M | -9.00M | -9.90M | |||
| INVESTING CASH FLOW | -3.17M | -4.60M | -55.00M | -39.10M | -29.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.60M | -4.09M | 7.58M | 12.10M | 16.80M | |||
| Stock Issued/Repurchased | N/A | N/A | -3.22M | -1.70M | -700.00K | |||
| Other Financing Activity | 3.16M | 3.29M | 810.00K | -21.20M | -1.80M | |||
| FINANCING CASH FLOW | 8.56M | -800.00K | 5.17M | -10.80M | 14.40M | |||
| CHANGE IN CASH | -870.00K | -15.40M | -59.48M | -45.00M | 95.20M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.07M | -10.00M | -9.65M | 4.90M | 109.80M | |||
| Capital Expenditure | -4.35M | -4.84M | -40.00M | -30.10M | -19.00M | |||
| FREE CASH FLOW | -10.42M | -14.84M | -49.65M | -25.20M | 90.80M | |||
All data in EUR